Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trial.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 16124951)

Published in Am Heart J on April 01, 2005

Authors

Shaun Goodman¹

Author Affiliations

1: St. Michael's Hospital, Toronto, Ontario, Canada. goodmans@smh.toronto.on.ca

Articles citing this ↘

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ (2012) 1.51